Elevation Oncology Inc. (ELEV:NASDAQ) shot up at $2.84, representing a gain of 17.8%. The stock got featured on our News Catalysts scanner on Wed, Apr 27, 2022 at 10:09 AM in the 'BIOTECH' category. From Wed, Apr 13, 2022, the stock recorded 50.00% Up Days and 44.44% Green Days
The share price of the company has been moving sideways in recent weeks.
About Elevation Oncology Inc. (ELEV:NASDAQ)
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.
Top 10 Gainers:
- Acutus Medical Inc. (AFIB:NASDAQ), 36%
- Locafy Limited (LCFY:NASDAQ), 34.19%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 30.08%
- Studio City International Holdings Limited (MSC:NYSE), 29.73%
- Canterbury Park Holding Corporation (CPHC:NASDAQ), 22.24%
- Bon Natural Life Limited (BON:NASDAQ), 18.54%
- Elevation Oncology Inc. (ELEV:NASDAQ), 17.84%
- PAVmed Inc. (PAVM:NASDAQ), 16.51%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 16.36%
- Chindata Group Holdings Limited (CD:NASDAQ), 15.34%